Centurion+ Patent Holders as of April 30, 2024

Joseph E Kovarik
Patent Attorney with Bioscience Focus, Shareholder Sheridan Ross, P.C.
Joe practices intellectual property law, with an emphasis in patent prosecution, patent litigation, mediation of patent disputes and in the licensing of intellectual property rights.
With his technical training in biochemistry and molecular, cellular and developmental biology, Joe represents many innovators in the medical device and biosciences fields. His varied practice includes both patent prosecution and enforcement of intellectual property rights, often involving the mediation, arbitration or litigation of intellectual property issues.
For over 25 years, Joe has prosecuted hundreds of patents to issuance, structured numerous licensing transactions, and participated in arbitrations, mediations, litigations, and appeals. He has developed a varied practice directed towards the appreciation of intellectual property values and the pursuit of opportunities to advance the interests of his clients.
Joe has also recently served as a visiting professor for the Daniels College of Business at Denver University in its Executive MBA Program offering an Overview of Intellectual Property Law.
Joe is involved with various charitable groups, previously serving on the board of The Children’s Hospital Research Foundation. He has also taught intellectual property law classes as an adjunct professor at the University of Denver, is a guest lecturer at CU’s Entrepreneurship school and presents at various inventor groups in the Denver area.
Patent №: 11969445 (April 30, 2024) – Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH. This method and system aim to modulate an individual’s microbiome to improve health outcomes for those overweight, obese, or suffering from cardiometabolic or inflammatory bowel diseases. Specific focus is on reducing the incidence of chronic conditions like NAFLD and NASH through bacterial formulations.

Amit Gradstein
Principal Engineer at Intel Israel Corporation Ltd.

Patent №: 11972230 (April 30, 2024) – Matrix transpose and multiply. A processor includes a decoder and execution circuitry. The decoder decodes an instruction specifying opcode, destination, and source matrix locations. The execution circuitry transposes the first source matrix, multiplies it with the second source matrix, and stores the result in the destination matrix location.

Amitava Gupta
Executive Vice President & Chief Technical Officer.

Patent №: 11971615 (April 30, 2024) – Electro-switchable spectacles for myopia treatment. It includes an electroactive component positioned away from the lens’s central axis to illuminate the peripheral retina, reducing myopia progression. The component also allows viewing through an optical zone while scattering light. Additionally, it can switch to a transparent mode for regular vision correction and viewing.

Scott A Linn
Specialties: Digital IC design, design tool flow (entire flow from specification, Verilog and through layout and debug), managing the IC design process, IC test

Patent №: 11969998 (April 30, 2024) – Multiple circuits coupled to an interface. This IC drives multiple fluid actuation devices with an interface, digital circuit, analog circuit, and control logic. The digital circuit sends a digital signal, while the analog circuit sends an analog one, both through the interface. Control logic activates either the digital or analog circuit as needed.
Patent №: 11969995 (April 30, 2024) – Integrated circuits including memory cells. This fluid ejection device consists of fluid actuation devices, memory cells, and a configuration register. Each memory cell corresponds to a fluid actuation device. The configuration register holds data to enable or disable access to the memory cells.